Naturally Derived SENP1 Inhibitors with Anticancer Activity

Area of Science:

• Biochemistry
• Molecular Biology
• Cellular Biology

Background:

• SENP1 (sentrin-specific protease 1) regulates sumoylation, a key post-translational modification essential for cellular processes like DNA repair and apoptosis.
• Dysregulation of sumoylation is implicated in pathological conditions, particularly cancer.
• Natural compounds offer potential therapeutic avenues by modulating enzyme activity.

Purpose of the Study:

• To review natural compounds that inhibit SENP1 activity.
• To explore the potential of these natural SENP1 inhibitors in cancer therapy.
• To discuss the mechanism of interaction between inhibitors and the SENP1 active site.

Main Methods:

• Literature review of experimental data on natural SENP1 inhibitors.
• Analysis of the structure-activity relationship of identified compounds.
• Discussion of the impact of SENP1 inhibition on sumoylation levels and cellular functions.

Main Results:

• Several natural compounds, including momordin Ic, hinokiflavone, and triptolide, demonstrate effective inhibition of SENP1.
• These inhibitors influence sumoylated protein levels and related cellular processes.
• Some natural inhibitors directly interact with the SENP1 active site.

Conclusions:

• Natural SENP1 inhibitors represent a promising strategy for cancer treatment.
• These compounds may offer a means to overcome resistance to conventional chemotherapies.
• Further research into the interaction mechanisms can guide the development of novel cancer therapeutics.